Champions Oncology appoints Brady Davis as President, effective Oct 9, 2023

CHAMPIONS ONCOLOGY, INC.

Brady Davis appointed President; annual base salary of $425,000 plus 50% target bonus.
Davis receives 135,000 stock options vesting over 4 years and 7,500 vesting over 1 year.
Davis brings 25+ years experience from Illumina, Oracle, Hewlett Packard, DNAnexus, and Canexia Health.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Brady Davis

President

CSBR · CHAMPIONS ONCOLOGY, INC.

Effective: 2023-10-09
Filed: October 17, 2023, 7:59 PM ET

On October 17, 2023, Champions Oncology, Inc. (the “Company”) announced the hiring and appointment of Brady Davis to serve as the Company’s President, effective as of October 9, 2023.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Brady Davis was appointed as President at CHAMPIONS ONCOLOGY, INC..

Action: appointed
Role: President

Exact text from the filing

On October 17, 2023, Champions Oncology, Inc. (the “Company”) announced the hiring and appointment of Brady Davis to serve as the Company’s President, effective as of October 9, 2023.

View on SEC.gov

CHAMPIONS ONCOLOGY, INC. filing history →

Source: SEC EDGAR

accession 0001628280-23-034475

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.